default author photo

Anthony L. Cunningham

The University of Sydney - Westmead Institute for Medical Research

Sydney

Australia

SCHOLARLY PAPERS

3

DOWNLOADS

237

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old

Number of pages: 38 Posted: 21 Mar 2024
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, The University of Western Australia, Scientia Clinical Research Ltd, University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - NSW Health Pathology, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, The University of Sydney - Westmead Hospital, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Technovalia Pty. Ltd., Technovalia Pty. Ltd., BioNet-Asia Co Ltd and The University of Sydney - Westmead Institute for Medical Research
Downloads 115 (617,542)

Abstract:

Loading...

DNA, SARS-CoV-2, vaccine, neutralising antibody, COVID-19, safety, immunogenicity

2.

Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level

Number of pages: 19 Posted: 21 Dec 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), University of Newcastle - Hunter Medical Research Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Sydney Institute for Infectious Diseases, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG, CSL Behring AG, CSL Behring AG, Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney, Garvan Institute of Medical Research, University of Newcastle (Australia) - Viral Immunology and Respiratory Disease Group, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Government of New South Wales - Virology Research Laboratory, The University of Sydney - School of Medical Sciences, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 90 (742,061)

Abstract:

Loading...

SARS-CoV-2Covid-19Neutralising antibodiesSotrovimabEvusheld

3.

An in situ Quantitative Map of Initial Human Colorectal HIV Transmission

Number of pages: 147 Posted: 03 May 2022
The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - School of Mathematics and Statistics, University of Newcastle, Oregon Health and Science University - Vaccine and Gene Therapy Institute, The University of Sydney, The University of Sydney - Westmead Institute for Medical Research and The Westmead Institute for Medical Research - Centre for Virus Research
Downloads 32 (1,290,922)

Abstract:

Loading...

HIV transmission, human tissue, in situ quantification, image processing algorithms